Verition Fund Management
TMDX icon

Verition Fund Management’s Transmedics TMDX Stock Holding History

Verition Fund Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,100
Closed -$2.08M – 3516
2025
Q4 		$2.08M Sell
17,100
-10,146
-37% -$1.27M 0.01% 1582
2025
Q3 		$3.06M Sell
27,246
-12,660
-32% -$1.48M 0.01% 1620
2025
Q2 		$5.35M Buy
39,906
+27,858
+231% +$3.06M 0.02% 1039
2025
Q1 		$811K Buy
+12,048
New +$829K ﹤0.01% 2276
2024
Q4 		– Sell
-9,227
Closed -$1.45M – 3525
2024
Q3 		$1.45M Sell
9,227
-4,858
-34% -$749K 0.01% 1623
2024
Q2 		$2.12M Buy
14,085
+7,269
+107% +$872K 0.01% 1233
2024
Q1 		$504K Buy
+6,816
New +$562K ﹤0.01% 1999
2023
Q4 		– Sell
-6,902
Closed -$378K – 2681
2023
Q3 		$378K Buy
+6,902
New +$497K ﹤0.01% 1597

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's TMDX Position: Q1 2026 in Review

Verition Fund Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 17,100 shares — an estimated $2.08M sold.

Verition Fund Management first reported a position in TMDX in Q3 2023 and held it in 8 quarters. The position peaked at $5.35M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Verition Fund Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 17,100 Transmedics shares in Q1 2026, an estimated $2.08M.
  • Verition Fund Management first reported a position in Transmedics in Q3 2023 and held it in 8 quarters.
  • Verition Fund Management's Transmedics position peaked at $5.35M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.